Skip to content

Clinical trials

Phase 1/2 Gastrointestinal Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Neoplasms Phase: Phase 1/2 Country / region: France Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20173
20201
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bolt Biotherapeutics, Inc.1
GlaxoSmithKline1
Hoffmann-La Roche1
Institut Cancerologie de l'Ouest1
Institut du Cancer de Montpellier - Val d'Aurelle1
Marengo Therapeutics, Inc.1
Merck Sharp & Dohme LLC1
Revolution Medicines, Inc.1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Neoplasms9
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Head and Neck Neoplasms4
Lung Neoplasms4
Neoplasms4
Neoplasms by Site4
Bronchial Neoplasms3
Carcinoma3
Colonic Neoplasms3

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.